Suhasini Sil: Mitigating Grade III Plateletpheresis Reactions – A Prospective Evaluation
Suhasini Sil, Senior Resident doctor at AIIMS, shared a post on LinkedIn about a recent article she and her colleagues co-authord, published in Transfusion Clinique et Biologique, adding:
“Excited to share our original research is recently accepted for publication in Transfusion Clinique et Biologique
‘Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis’
Key findings:
- Donor education and active monitoring increased ADR detection nearly four-fold (9.3% vs. 2.3%).
- All reactions identified in the intervention group were mild (Grade I), with no Grade II or Grade III reactions observed.
- The odds of severe donor reactions were reduced by 98% with proactive donor engagement.
- Early recognition of symptoms improved donor safety, donor experience, and may support long-term donor retention.
A heartfelt thanks to all co-authors, donors, nursing staff, and colleagues who contributed to this work.”
Title: Prospective evaluation of pre-procedure education and active monitoring in reducing grade III donor reactions in plateletpheresis
Authors: Suhasini Sil, Hem Chandra Pandey, Manvi Talwar, Chanchi Khiamniungan, Lubna Naseer, Poonam Coshic

Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?